pravastatin has been researched along with leupeptins in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Gao, F; Gui, YZ; Ma, YL; Wang, SM; Wang, XB; Wang, YP; Yan, H | 1 |
1 other study(ies) available for pravastatin and leupeptins
Article | Year |
---|---|
MG132, a proteasome inhibitor, enhances LDL uptake in HepG2 cells in vitro by regulating LDLR and PCSK9 expression.
Topics: Anticholesteremic Agents; Gene Expression Regulation; Hep G2 Cells; Humans; Leupeptins; Lipoproteins, LDL; Liver; Pravastatin; Proprotein Convertase 9; Proprotein Convertases; Proteasome Endopeptidase Complex; Proteasome Inhibitors; Protein Kinase C; Real-Time Polymerase Chain Reaction; Receptors, LDL; Serine Endopeptidases | 2014 |